In the article by Oki E et al, entitled “Trifluridine/tipiracil plus bevacizumab as a first‐line treatment for elderly patients with metastatic colorectal cancer (KSCC1602): A multicenter phase II trial,” 1 Dr. Kotaka's first name has been corrected and his full name should read “Masahito Kotaka.”
REFERENCE
- 1. Oki E, Makiyama A, Miyamoto Y, et al. Trifluridine/tipiracil plus bevacizumab as a first‐line treatment for elderly patients with metastatic colorectal cancer (KSCC1602): a multicenter phase II trial. Cancer Med. 2021;10:454‐461. [DOI] [PMC free article] [PubMed] [Google Scholar]